Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,661 across all filing types
Latest filing 2020-09-05 Regulatory Filings
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (National Stock Exchange of India Ltd. and Bombay Stock Exchange Limited) regarding the loss of share certificates by shareholders and the request for issuance of duplicate share certificates. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to reporting such events. The content is about notifying the exchange of lost share certificates and does not contain financial data, earnings, management discussion, or any report publication. It is a regulatory announcement related to share certificates but not a financial report or management information. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-09-05 English
Morepen Laboratories Ltd has informed BSE regarding loss of share Certificates of the Company
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (National Stock Exchange of India Ltd. and BSE Limited) regarding the loss of share certificates by shareholders and the request for issuance of duplicate share certificates. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to reporting such events. The content is about notifying the stock exchanges of lost share certificates and related administrative details, not about financial results, management changes, or other report types. It is not a financial report, earnings release, or management discussion. It is a regulatory compliance announcement related to share certificates. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-09-05 English
Please find enclosed Annual Report of the Company for the Financial Year 2019-20, pursuant to the provisions of Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) ....
Annual Report Classification · 100% confidence The document is titled 'Annual Report 2019-20' and is addressed to stock exchanges, indicating it is an official yearly report. It references the financial year 2019-20 and includes detailed sections such as Directors' Report, Independent Auditors' Report, Balance Sheet, Profit and Loss Statement, Cash Flow Statement, and Notes on Financial Statements. The length of the document is substantial (15,000 characters), and it contains comprehensive financial and corporate information rather than just an announcement or a brief summary. Therefore, it fits the definition of an Annual Report (10-K).
2020-09-05 English
Shareholders meeting
Regulatory Filings
2020-09-05 English
Pursuant to Regulation 30 read with Part A of Schedule III of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, as amended, please ....
AGM Information Classification · 100% confidence The document is a detailed notice of the 35th Annual General Meeting (AGM) of Morepen Laboratories Limited. It includes the date and time of the AGM, the agenda items such as adoption of financial statements, appointment of directors, amendments to the Memorandum of Association, increase in authorized share capital, and increase in remuneration of the Chairman & Managing Director. The document is addressed to stock exchanges and shareholders, and it references regulatory compliance with SEBI and Companies Act provisions. There is no actual financial data or report content, but rather a formal notice and agenda for the AGM. Therefore, this document fits the category of AGM Information (AGM-R).
2020-09-05 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (National Stock Exchange of India Ltd. and BSE Limited) regarding the issuance of duplicate share certificates and the loss of original share certificates. It references Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management. The content includes detailed lists of shareholders, folio numbers, old and new certificate numbers, and requests for duplicate certificates due to loss. There is no financial data, earnings information, management discussion, or report publication mentioned. The document is a regulatory announcement informing the stock exchanges and public about share certificate replacements and losses, which fits the category of a Regulatory Filing (RNS) as it is a compliance-related disclosure that does not fit into other specific categories like capital changes or director dealings.
2020-09-01 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.